相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
Lihong Liu et al.
NATURE (2022)
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
A. Jayk Bernal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332
Yao Zhao et al.
PROTEIN & CELL (2022)
Efficacy and safety of arbidol (umifenovir) in patients with COVID-19: A systematic review and meta-analysis
Behnam Amani et al.
IMMUNITY INFLAMMATION AND DISEASE (2021)
Clinical Antiviral Drug Arbidol Inhibits Infection by SARS-CoV-2 and Variants through Direct Binding to the Spike Protein
Anton Shuster et al.
ACS CHEMICAL BIOLOGY (2021)
A review of potential suggested drugs for coronavirus disease (COVID-19) treatment
Parastoo Tarighi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19
Ilaria Vicenti et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2021)
A review on favipiravir: the properties, function, and usefulness to treat COVID-19
Seyed MohammadReza Hashemian et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2021)
SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis
Armin Bayati et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Drug repurposing approach to combating coronavirus: Potential drugs and drug targets
Jimin Xu et al.
MEDICINAL RESEARCH REVIEWS (2021)
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
A. C. Kalil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Goran Kokic et al.
NATURE COMMUNICATIONS (2021)
Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial
Jordana B. Cohen et al.
LANCET RESPIRATORY MEDICINE (2021)
Modeling the Binding Mechanism of Remdesivir, Favilavir, and Ribavirin to SARS-CoV-2 RNA-Dependent RNA Polymerase
Fabian Bylehn et al.
ACS CENTRAL SCIENCE (2021)
Major Update: Remdesivir for Adults With COVID-19: A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points
Anjum S. Kaka et al.
ANNALS OF INTERNAL MEDICINE (2021)
AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19
Steven S. Good et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Natural Polyphenols as Immunomodulators to Rescue Immune Response Homeostasis: Quercetin as a Research Model against Severe COVID-19
Roberta Bernini et al.
MOLECULES (2021)
Merck’s COVID pill loses its lustre: what that means for the pandemic
Max Kozlov
NATURE (2021)
Nanometer-resolution in situ structure of the SARS-CoV-2 postfusion spike protein
Linhua Tai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
Kris M. White et al.
SCIENCE (2021)
An overview of ProTide technology and its implications to drug discovery
Michaela Serpi et al.
EXPERT OPINION ON DRUG DISCOVERY (2021)
Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials
Rodolfo Pedro Rothlin et al.
FRONTIERS IN PHARMACOLOGY (2021)
Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review
Sultan A. M. Saghir et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2021)
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines
Andrew Bryant et al.
AMERICAN JOURNAL OF THERAPEUTICS (2021)
The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable
Jack M. Lawrence et al.
NATURE MEDICINE (2021)
Structural biology of SARS-CoV-2 and implications for therapeutic development
Haitao Yang et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Molnupiravir: coding for catastrophe
Brandon Malone et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)
The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
Soheil Hassanipour et al.
SCIENTIFIC REPORTS (2021)
Current status of therapeutic monoclonal antibodies against SARS-CoV-2
Sanjeev Kumar et al.
PLOS PATHOGENS (2021)
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER) : a randomised, double-blind, parallel-group, placebo- controlled phase 3 trial
Vincent C. Marconi et al.
LANCET RESPIRATORY MEDICINE (2021)
Efficacy and safety of lopinavir-ritonavir in COVID-19: A systematic review of randomized controlled trials
Tejas K. Patel et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2021)
Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza
Yalda Rahbar Saadat et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Plitidepsin: Mechanisms and Clinical Profile of a Promising Antiviral Agent against COVID-19
Michail Papapanou et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
The JAK/STAT signaling pathway: from bench to clinic
Xiaoyi Hu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape
John S. Tregoning et al.
NATURE REVIEWS IMMUNOLOGY (2021)
A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19
Michael A. Puskarich et al.
ECLINICALMEDICINE (2021)
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial
Jesper D. Gunst et al.
ECLINICALMEDICINE (2021)
Ivermectin for preventing and treating COVID-19
Maria Popp et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
Eva Schrezenmeier et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
Drug Development and Medicinal Chemistry Efforts toward SARS-Coronavirus and Covid-19 Therapeutics
Arun K. Ghosh et al.
CHEMMEDCHEM (2020)
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Christian A. Devaux et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy
Sukbin Jang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
COVID-19 illness in native and immunosuppressed states: A clinical?therapeutic staging proposal
Hasan K. Siddiqi et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)
COVID-19: Drug Targets and Potential Treatments
Carmen Gil et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19
Minchen Chien et al.
JOURNAL OF PROTEOME RESEARCH (2020)
Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19
Robert L. Hoffman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir
Giovanni Bolcato et al.
SCIENTIFIC REPORTS (2020)
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
Mei-Yue Wang et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Interleukin-6: Biology, signaling and strategies of blockade
Fred Schaper et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Roles, regulation and inhibitors of sphingosine kinase 2
Heidi A. Neubauer et al.
FEBS JOURNAL (2013)
Mechanism of Inhibition of Enveloped Virus Membrane Fusion by the Antiviral Drug Arbidol
Elodie Teissier et al.
PLOS ONE (2011)